<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The <z:chebi fb="105" ids="17234">glucose</z:chebi> regulated heat shock protein 78 (GRP78) is a central regulator of ER (endoplasmic reticulum) stress due to its pro-survival property </plain></SENT>
<SENT sid="1" pm="."><plain>Up regulated GRP78 expression in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells has been correlated with aggressive <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> whereas some reports have predicted an improved prognosis </plain></SENT>
<SENT sid="2" pm="."><plain>Over-expression of GRP78 in the ER promotes its localization to the cell surface on several cell types including <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: In order to elucidate whether GRP78 receptor positive and negative <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells manifest different properties in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, we first artificially separated GRP78 positive and negative sub-populations from HM7 and HCT116 cell lines using anti GRP78 antibody coated magnetic beads </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Only GRP78 negative cells were highly proliferative, induced significant growth in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size in <z:mp ids='MP_0003815'>nude</z:mp> mice and metastasized to the liver in a human metastatic colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> model in mice </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast, GRP78 positive cells manifested reduced proliferation, colony formation, <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> and <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The reduced tumorigenicity of GRP78 positive subpopulation was abrogated by silencing GRP78 expression using siRNA oligomers </plain></SENT>
<SENT sid="7" pm="."><plain>In our efforts to induce cell surface GRP78, we subjected the cells to <z:chebi fb="0" ids="28748">doxorubicin</z:chebi> and <z:chebi fb="6" ids="45863">taxol</z:chebi> that increased significantly the percent of GRP78 positive population </plain></SENT>
<SENT sid="8" pm="."><plain>Cells pre-incubated with <z:chebi fb="0" ids="28748">doxorubicin</z:chebi> exhibited reduced proliferation and <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> in mice </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: This study demonstrates the significance of cell surface GRP78 in <z:hpo ids='HP_0003003'>colon cancer</z:hpo>, which may be used as a marker for reduced tumorigenicity </plain></SENT>
</text></document>